Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Mar 2023 for Abbott Laboratories, €266k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher J. Calamari: trading record in brief
This profile gathers the share dealings of Christopher J. Calamari in Abbott Laboratories, where the filings describe the role as chief executive. In total, 6 filings cover trades dated from 1 July 2021 to 28 February 2023.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 2 March 2023 with a share grant (€266k) in Abbott Laboratories. Typically, a trade is published a median of 5 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher J. Calamari
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
2,827 shares@ US$99.7745.5% of flowCommon shares without par valueSEC:0001415889-23-003896:0
10,560 shares0Common shares without par valueSEC:0001415889-23-003047:0
569 shares@ US$108.650.0000% mcap18.5% of flowCommon shares without par valueSEC:0001415889-22-007180:0
2,368 shares@ US$122.4144.4% of flowCommon shares without par valueSEC:0001415889-22-002187:0
12,812 shares0Common shares without par valueSEC:0001415889-22-001731:0
3,764 shares0Common shares without par valueSEC:0001415889-21-003509:0
6 of 6 declarations
